Interview with Dr. Humayra Ali: The "Value" of Covid Vaccines

Written By Humayra Ali

Designing New Business Models for the Health Industry and Beyond

Dr. Humayra Ali interviews with BIONOWIN Santé Ave Association. BIONOWIN is focused on professional training for pharmaceutical, biotechnology and health care professionals. Interview focuses on the "value" of COVID-19 vaccine in designing new business models for the health industry, the impact of different COVID vaccines on future research programs, and the urgency of education for public and professionals.

Disclaimer: Vaxtherapy is NOT affiliated with any of the pharma/biotech companies working on COVID-19 vaccines. The purpose of this post is to provide education and awareness from a virologist’s independent perspective based on available facts and data.

Like what you see, and want to stay up-to-date? Subscribe to the VaxTherapy RSS Feed and don't forget to leave a comment below.

Check out our latest, engaging post as we discuss why to trust the Covid-19 / Coronavirus vaccine despite being made in such a rapid pace!

Humayra Ali
Previous

What Does the Advent of Mutant Coronavirus Strains Mean for Vaccine Efficacy (Best- and Worst-Case Scenarios)?
Next

Why Trust the COVID-19 (Coronavirus) Vaccines Despite Being Made in Record Time?